Identifying the Optimal Dynamic Ankle-Foot Orthosis Bending Stiffness for Individuals Post-Stroke
Launched by UNIVERSITY OF DELAWARE · Mar 4, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to make ankle braces, called AFOs (ankle-foot orthoses), work better for people who have had a stroke. These braces help support the ankle and improve walking, but there isn't a standard way to choose the right one for each person. The researchers want to find out how different levels of support from these braces can help improve walking ability. Participants will try on a brace with five different levels of assistance while their walking performance and experiences are monitored.
To be eligible for this study, participants should be at least six months post-stroke, have been prescribed an AFO, and have some weakness in their ankle muscles. However, certain individuals, such as those with additional neurological conditions or severe mobility issues, won’t be included. If you participate, you can expect to walk with various brace settings and share your feedback, which will help create guidelines for clinicians to better match braces to patients' needs in the future. This trial is an important step toward ensuring that stroke survivors receive the best possible support for their recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • chronic stroke (\> 6 months post-stroke)
- • been prescribed an AFO by a clinician
- • have plantar flexor strength deficits (unable to complete at least 25 standing heel-raises
- • have at least 5 degrees of passive dorsiflexion range of motion (as measured during the clinical evaluation in Visit 1).
- Exclusion Criteria:
- • Those that will not be included in this study are individuals with 1) Evidence of cerebellar stroke on clinical MRI, 2) Other neurologic conditions in addition to stroke, 3) Sensorimotor neglect, 4) Inability to walk outside the home prior to the stroke, 5) Total joint replacement or orthopedic problems in the lower limbs or spine that limit walking, 6) Coronary artery bypass graft or myocardial infarction within past 3 months, 7) Unexplained dizziness in last 6 months, 8) Inability to communicate with investigators, 9) Lack of decisional capacity.
About University Of Delaware
The University of Delaware, a renowned research institution, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, engineering, and behavioral health, to conduct rigorous and ethical research. The university's commitment to scientific excellence and community engagement ensures that its clinical trials not only contribute to groundbreaking discoveries but also prioritize participant safety and well-being. Through its state-of-the-art facilities and a team of experienced researchers, the University of Delaware is positioned to make significant contributions to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, Delaware, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported